(Q44833256)

English

Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study

scientific article published in April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Rank order of success favors longer duration of imidazole-based therapy for Helicobacter pylori in duodenal ulcer disease: a randomized pilot study (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Helicobacter pylori

1 reference

based on heuristic

inferred from title

author name string

Ashmit Chaudhary

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Vineet Ahuja

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Chandrasekhar S Bal

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Bimal Das

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Ravinder Mohan Pandey

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Mahesh Prakash Sharma

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

publication date

1 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

124-129

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00208.X

21 January 2018

The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00208.X

21 January 2018

The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00208.X

21 January 2018

Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00208.X

21 January 2018

Evaluation of treatment regimens to cure Helicobacter pylori infection--a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00208.X

21 January 2018

Antimicrobial treatment of H. pylori infection--a pooled efficacy analysis of eradication therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00208.X

21 January 2018

Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00208.X

21 January 2018

Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00208.X

21 January 2018

Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00208.X

21 January 2018

Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00208.X

21 January 2018

Antibiotic resistance of Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00208.X

21 January 2018

A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00208.X

21 January 2018

High recurrence rate of Helicobacter pylori infection in developing countries

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00208.X

21 January 2018

The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00208.X

21 January 2018

Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach

1 reference

https://api.crossref.org/works/10.1111%2FJ.1083-4389.2004.00208.X

21 January 2018

Identifiers

10.1111/J.1083-4389.2004.00208.X

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44833256&oldid=2048842646"